
Is Pyxis Oncology Running Out of Time? A Closer Look at Its Cash Burn Dilemma
Pyxis Oncology faces a financial challenge with its current $145 million cash reserve offset by a $54 million annual cash burn, giving it a runway of approximately 2.7 years. The company has reduced its cash burn by 34% in the past year,